Open Access
Article
Role of bone morphogenetic proteins and their antagonists in healing of bone fracture
D Brian Dean1,J Tracy Watson1,Berton R Moed1,Zijun Zhang1
1
Department of Orthopaedic Surgery, Saint Louis University, 3635 Vista Avenue, St. Louis MO 63110, USA
DOI: 10.2741/3419 Volume 14 Issue 8, pp.2878-2888
Published: 01 January 2009
Abstract

Recent advances have allowed elucidation of the factors which are important to the healing of bone fracture. The bone morphogenetic proteins (BMPs) of the transforming growth factor-beta (TGF-beta) family have emerged as an effective therapeutic target in the treatment of severe fractures and fracture non-unions which have been resistant to conventional treatment. Treatment with BMP has provided encouraging results, both in animals and humans. Such treatments have reduced the time required for a fracture to heal and have increased the strength of the healed bone. BMP antagonists have been shown to modulate BMP activities in diverse and critical ways in a myriad of tissues and systems during normal vertebrate development. Recent studies have begun investigating the role of BMP antagonists during bone development and in healing of fractures. Better understanding of the effects of such antagonists in the healing of fractures opens the possibility of enhancing those effects which are exerted solely by treatment with BMP.

Share and Cite
D Brian Dean, J Tracy Watson, Berton R Moed, Zijun Zhang. Role of bone morphogenetic proteins and their antagonists in healing of bone fracture. Frontiers in Bioscience-Landmark. 2009. 14(8); 2878-2888.